| Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents (NCT02964377) | Craig McDonald, MD | 2016-11-01 |
| Treatment Effect of Tamoxifen on Patients With DMD (NCT02835079) | Hadassah Medical Organization | 2016-11-01 |
| An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy (NCT02907619) | Pfizer | 2016-10-13 |
| Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) (NCT02500381) | Sarepta Therapeutics, Inc. | 2016-09-28 |
| An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) (NCT02760277) | ReveraGen BioPharma, Inc. | 2016-07-28 |
| Study of Ataluren in ≥2 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy (NCT02819557) | PTC Therapeutics | 2016-06-09 |
| A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) (NCT02760264) | ReveraGen BioPharma, Inc. | 2016-06-01 |
| Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD (NCT02972580) | Nationwide Children's Hospital | 2016-06-01 |
| Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD) (NCT02858362) | Summit Therapeutics | 2016-06-01 |
| A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy (NCT02752048) | Taiho Pharmaceutical Co., Ltd. | 2016-05-01 |
| Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD) (NCT02958202) | BioMarin Pharmaceutical | 2016-04-01 |
| Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2 (NCT02704325) | Kevin Flanigan | 2016-04-01 |
| Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases (NCT03786913) | Benha University | 2016-03-08 |
| Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy (NCT02891434) | University of Sao Paulo | 2016-02-01 |
| HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) (NCT02485938) | Capricor Inc. | 2016-01-07 |
| Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) (NCT02606136) | Kyntra Bio | 2016-01-04 |
| Virtual Reality in Individuals With Duchenne Muscular Dystrophy (NCT03002298) | University of Sao Paulo | 2016-01-01 |
| Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients (NCT02530905) | Sarepta Therapeutics, Inc. | 2015-10-08 |
| Study of DS-5141b in Patients With Duchenne Muscular Dystrophy (NCT02667483) | Daiichi Sankyo Co., Ltd. | 2015-10-01 |
| Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy (NCT03067831) | Stem Cells Arabia | 2015-09-01 |
| Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2 (NCT02484560) | University of Gaziantep | 2015-06-01 |
| Strength Training in Duchenne Muscular Dystrophy (NCT02421523) | University of Florida | 2015-05-30 |
| Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy (NCT02354352) | Ohio State University | 2015-03-20 |
| Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy (NCT02376816) | Jerry R. Mendell | 2015-03-01 |
| Biomarker Development for Muscular Dystrophies (NCT05019625) | Massachusetts General Hospital | 2015-02-20 |
| Phase I/II Study of SRP-4053 in DMD Patients (NCT02310906) | Sarepta Therapeutics, Inc. | 2015-01-13 |
| Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy (NCT02354781) | Jerry R. Mendell | 2015-01-01 |
| A Device for Rapid, Painless, Bedside Muscle Evaluation of Children (NCT02340923) | Skulpt, Inc. | 2015-01-01 |
| An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort (NCT02295748) | PTC Therapeutics | 2014-12-01 |
| Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD) (NCT02329769) | BioMarin Pharmaceutical | 2014-12-01 |
| A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy (NCT02310763) | Pfizer | 2014-11-24 |
| Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy (NCT01834040) | Chaitanya Hospital, Pune | 2014-09-01 |
| A Study of TAS-205 for Duchenne Muscular Dystrophy (NCT02246478) | Taiho Pharmaceutical Co., Ltd. | 2014-09-01 |
| Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy. (NCT01834066) | Chaitanya Hospital, Pune | 2014-09-01 |
| European Home Mechanical Ventilation Registry (NCT02315339) | ResMed | 2014-08-01 |
| Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle (NCT02168114) | University of Florida | 2014-07-01 |
| Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies (NCT02109692) | University Hospital, Montpellier | 2014-05-19 |
| Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients (NCT02196467) | CHU de Quebec-Universite Laval | 2014-05-01 |
| Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy (NCT02167217) | Washington University School of Medicine | 2014-04-17 |
| Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task (NCT04607824) | University of Sao Paulo | 2014-03-01 |
| Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy (NCT02034305) | University of Pittsburgh | 2014-01-01 |
| 2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children (NCT02418338) | University Hospital, Montpellier | 2014-01-01 |
| A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD) (NCT02056808) | Summit Therapeutics | 2013-11-01 |
| Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy (NCT02285673) | Acibadem University | 2013-11-01 |
| Open Label Extension Study of HT-100 in Patients With DMD (NCT01978366) | Processa Pharmaceuticals | 2013-10-01 |
| Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life. (NCT01963897) | Oslo University Hospital | 2013-08-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Exploratory Study of NS-065/NCNP-01 in DMD (NCT02081625) | National Center of Neurology and Psychiatry, Japan | 2013-06-01 |
| A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD) (NCT01957059) | BioMarin Pharmaceutical | 2013-06-01 |
| Duchenne Muscular Dystrophy Clinical Trial (NCT01874275) | Alan Neuromedical Technologies, LLC | 2013-06-01 |
| Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy (NCT01847573) | Processa Pharmaceuticals | 2013-05-01 |
| Stacking Exercises Aid the Decline in FVC and Sick Time (NCT01999075) | Children's Hospital of Eastern Ontario | 2013-03-01 |
| Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy (NCT04740554) | University of Sao Paulo | 2013-03-01 |
| Upper Limb Assessment in Duchenne Muscular Dystrophy (NCT02436720) | Catholic University of the Sacred Heart | 2013-01-01 |
| Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy (NCT01826474) | BioMarin Pharmaceutical | 2013-01-01 |
| A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy. (NCT01753804) | BioMarin Pharmaceutical | 2012-09-01 |
| Pediatric Radio Frequency Coils Generic (NCT01633866) | Children's Hospital Medical Center, Cincinnati | 2012-07-01 |
| Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada (NCT01557400) | PTC Therapeutics | 2012-05-20 |
| Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy (NCT01491555) | Boston Children's Hospital | 2012-04-01 |
| PDE Inhibitors in DMD Study (Acute Dosing Study) (NCT01580501) | Cedars-Sinai Medical Center | 2012-03-01 |
| Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy (NCT01648634) | Assistance Publique - Hôpitaux de Paris | 2012-02-13 |
| Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy (NCT01521546) | Subha Raman | 2012-02-01 |
| DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls (NCT01523964) | Dart Therapeutics. LLC | 2012-02-01 |
| Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids (NCT01388764) | Massachusetts General Hospital | 2012-01-01 |
| Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin (NCT02516085) | University Hospital, Basel, Switzerland | 2012-01-01 |
| Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy (NCT01610440) | Shenzhen Beike Bio-Technology Co., Ltd. | 2011-10-01 |
| Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping (NCT01385917) | Genethon | 2011-10-01 |
| Flu Vaccine Study in Neuromuscular Patients 2011 (NCT01422200) | Children's Hospital Medical Center, Cincinnati | 2011-08-01 |
| Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy (NCT01645098) | Nationwide Children's Hospital | 2011-08-01 |
| Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients (NCT01396239) | Sarepta Therapeutics, Inc. | 2011-07-01 |
| Tadalafil and Sildenafil for Duchenne Muscular Dystrophy (NCT01359670) | Cedars-Sinai Medical Center | 2011-05-01 |
| Safety Study of Flavocoxid in Duchenne Muscular Dystrophy (NCT01335295) | University of Messina | 2011-03-01 |
| Optimum Insufflation Capacity in NMD (NCT01981915) | Universität Duisburg-Essen | 2011-01-01 |
| Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy (NCT01183767) | Charite University, Berlin, Germany | 2010-12-30 |
| Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) (NCT01247207) | PTC Therapeutics | 2010-11-30 |
| Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy (NCT01239758) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2010-10-01 |
| Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy (NCT01168908) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2010-09-01 |
| The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor (NCT01182324) | National Human Genome Research Institute (NHGRI) | 2010-07-30 |
| Cardiac Magnetic Resonance in Children With Muscular Dystrophy (NCT01081080) | Cooperative International Neuromuscular Research Group | 2010-04-01 |
| Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy (NCT01099761) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2010-04-01 |
| This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy (NCT01098708) | Washington University School of Medicine | 2010-03-01 |
| Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (NCT01126697) | Cooperative International Neuromuscular Research Group | 2010-02-01 |
| Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD) (NCT01009294) | PTC Therapeutics | 2010-01-13 |
| Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS) (NCT01125709) | Cooperative International Neuromuscular Research Group | 2010-01-01 |
| Cardiac Outcome Measures in Children With Muscular Dystrophy (NCT01066455) | Cooperative International Neuromuscular Research Group | 2010-01-01 |
| Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD) (NCT01037309) | BioMarin Pharmaceutical | 2009-12-01 |
| Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders (NCT00839033) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (NCT00873782) | University of North Carolina, Chapel Hill | 2009-03-01 |
| Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) (NCT00847379) | PTC Therapeutics | 2009-01-31 |
| Stem Cell Therapy in Duchenne Muscular Dystrophy (NCT02241434) | Neurogen Brain and Spine Institute | 2009-01-01 |
| Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients (NCT00844597) | Sarepta Therapeutics, Inc. | 2009-01-01 |
| Ramipril Versus Carvedilol in Duchenne and Becker Patients (NCT00819845) | Catholic University, Italy | 2008-12-01 |
| Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension) (NCT00758225) | Santhera Pharmaceuticals | 2008-09-01 |
| Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD) (NCT00759876) | PTC Therapeutics | 2008-08-13 |
| The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy (NCT00606775) | Suzuka Hospital | 2007-12-01 |
| Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy (NCT00159250) | Imperial College London | 2007-10-26 |
| Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons (NCT00451074) | Nationwide Children's Hospital | 2007-03-01 |
| Digestive Events in Duchenne Muscular Dystrophy Patients (NCT04384354) | Centre d'Investigation Clinique et Technologique 805 | 2007-01-01 |
| Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy (NCT00312247) | Shriners Hospitals for Children | 2006-04-01 |
| Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy (NCT00428935) | Nationwide Children's Hospital | 2006-03-01 |